SubMagna™ HMW Is Available at Independent Pharmacies Worldwide
Interested in Having Available At Your Pharmacy?
The usage of Sumatriptan for migraines or headaches is not new, and it is not novel. The drug has been available as a commercially available shot for injection and as a nasal spray for years. What is new is the ability to compound Sumatriptan with SubMagna™ HMW, to enable delivery in a sublingual (under the tongue) dosage form. To learn more about this SubMagna™ HMW base, review the information found at www.submagna.com.
Patients that are prescribed a compounded version of Sumatriptan often have a 25mg-1ml suspension selected by the prescriber with directions reflective of “place 1ml in the mouth and hold 2 minutes minimum then swallow for headache.”
If you’re looking for a compounding base to deliver Sumatriptan that can be absorbed through the mucosal tissue in the oral cavity, look no further than SubMagna™ HMW.
SubMagna™ HMW is a base available from PCCA. Any pharmacy that is a PCCA member, or alternatively, any pharmacy that is a licensee of Kingdom Licensing (without being a PCCA member), can obtain SubMagna™ HMW. SubMagna™ HMW is a trademark of Kingdom Licensing.
©CMPD Licensing, LLC dba Kingdom Licensing
Website Design by Storey Marketing
The content and photographs on this website are copyrighted or licensed material and may not be downloaded for other than personal use. Retransmission, republication, reproduction or any other use of the content or photographs is prohibited.